Opportunities and challenges go hand in hand, where do small and medium-sized pharmaceutical logistics companies go?
The pharmaceutical industry is closely related to people's lives and gradually takes a more important position in the national economy. The growing market share of the pharmaceutical industry has brought about the rapid development of the pharmaceutical logistics industry. However, at present, China's pharmaceutical logistics industry presents a pattern of multiple, small, scattered and chaotic, and the cost of drug circulation is high. Its Chinese medicine, Shanghai medicine, China Resources North Pharmaceutical and Kyushutong four pharmaceutical logistics enterprises rank in the top four, but throughout The industry accounts for less than 30%. With the advancement of society and the changes in the industry environment, where do many traditional small and medium-sized pharmaceutical logistics companies go? This article will analyze the two aspects of the opportunities and challenges it faces, and finally draw conclusions. In general, changes in the social environment are beneficial to its development. First of all, the pharmaceutical logistics market is gradually expanding. Statistics show that the total sales of China's seven major categories of pharmaceutical products in 2016 was about 1.83 trillion yuan, an increase of about 10% over 2015. It is expected that the scale of China's pharmaceutical market will exceed 2.2 trillion yuan in 2019. . According to the 1% logistics rate, the pharmaceutical logistics market will have a scale of 22 billion yuan in 2019, which can provide a broad space for development. Secondly, the relevant policies and systems are constantly improving. China's new round of medical reforms has entered a critical period, and requirements for further reform and improvement of the drug circulation system have been made. In addition, the State Council cancelled the approval of third-party drug logistics business in early 2016, and China's pharmaceutical companies or logistics services. Under the premise that the operation process complies with the GSP and relevant regulations, the company can independently provide third-party logistics services to various medical and health enterprises. Finally, new technologies and new ideas have emerged. For example, the use of WMS systems, electronic label picking systems, and RF handheld terminals has become widespread. Warehouse management has shown a trend of paperlessness and informationization. For example, Sinopharm and Zhejiang Inte. The representative enterprises adopt the national or provincial integrated multi-warehousing network operation system and multi-warehouse linkage service mode to realize linkage of various logistics centers and effectively improve operational efficiency. However, pharmaceutical logistics started late in China and its foundation is weak. There are still a series of problems in terms of current development, which is a great challenge to the entire industry, especially small and medium-sized pharmaceutical logistics enterprises. 1. The policy standards are not perfect. If the industrial and commercial policies and the drug supervision policies are not matched, the state drug supervision agency allows the chain enterprises to carry out vertical management and logistics distribution to the chain stores of different places across regions, and according to the policies of the industry and commerce department, even if the same legal entity is established within the same region. Branches are also branch companies, not chain enterprises; like the administrative segmentation and local protection of the pharmaceutical market, the drug bidding procurement policies of some regional medical institutions are tilted to local drug companies, and some logistics companies often encounter cars in other places. , deduction, or even a fine without justification. This undoubtedly increased the operating costs of pharmaceutical logistics, hindered the scale and network of pharmaceutical logistics, and the transformation and development of small and medium-sized pharmaceutical logistics enterprises with limited strength were particularly hindered. 2. The divested pharmaceutical logistics enterprises have not experienced the general development process of third-party logistics enterprises, and many third-party logistics enterprises have insufficient capabilities. For example, if the supply chain is single, most enterprises stay in the stage of internal import, sales, storage and business integration, and process optimization. They rarely involve integration of upstream and downstream, and cannot fundamentally solve problems such as repeated transportation and bullwhip effect; It is limited to the information resources within its own enterprise, and does not share information with customers and upstream and downstream enterprises in the supply chain. The role of internal information resources is extremely limited; the logistics facilities are backward, the technology content is low, and the logistics operations are mainly based on manual operations. For the more demanding medical cold chain is more difficult to meet. 3. The competition in the pharmaceutical circulation industry is becoming increasingly fierce. The merger and reorganization of large-scale pharmaceutical logistics enterprises has continued. For example, China Resources and Shanghai Pharmaceuticals continue to absorb outlets through mergers and acquisitions, and distribute the country to the goal of network, intensification and informationization. Social logistics enterprises have entered the market and entered medicine from SF Holdings. In the logistics market, Shanghai Pharmaceuticals joined forces with Deutsche Post. As the market gradually opened up, socialized and specialized pharmaceutical logistics companies became a trend. 4. Lack of logistics talents. According to industry experts, there are more than a hundred people who can truly be regarded as senior medical logistics talents. Currently, there are about 2,000 senior medical logistics talents in the country. That is to say, in the society, the number of medical logistics talents is less than 1/20 of the total demand, and the attraction of SMEs to talents is even more difficult. 5. The logistics concept is backward. Compared with the market requirements, the service concept and management level in the circulation of medicine still have a large gap. Most business leaders have insufficient understanding of logistics centers. The warehouses of most pharmaceutical distribution companies are the same, and the goods are handled in a traditional way, which is inefficient. In the coming period, it is a decisive period for building a well-off society in an all-round way. It is an important period for implementing the healthy China strategy and a crucial period for improving the quality and efficiency of the pharmaceutical logistics industry. Faced with the new situation of social development, small and medium-sized pharmaceutical logistics enterprises need to be properly transformed in order to survive and develop. 1. Conducting a transformation of the pharmaceutical supply chain. At present, the competition among enterprises has risen to the competition among supply chains. The pharmaceutical industry has the professional characteristics of linkage development of production, supply and marketing, and has outstanding advantages in developing modern supply chains. With the gradual opening up of the pharmaceutical market, the demand of customers continues to increase, and the upstream and downstream of the industrial chain are deepened and integrated, and the pharmaceutical supply chain will usher in a period of rapid growth. 2. Integrate the operation mode and management method, and seek cooperation with similar pharmaceutical circulation enterprises. Optimize the order of purchase and sale of drugs, compress the circulation of drugs, and improve their own strength and expand the existing market through mergers and acquisitions. 3. Make full use of local advantages and actively seize the terminal. With the continuous promotion of drug bidding and procurement, “two-vote system†and grading medical treatment, the outflow of prescription drugs has become a development trend. After the local market is stable, it should seek expansion of other regional markets. 4. The wisdom of medical logistics. Gradually build informatized and intelligent pharmaceutical logistics, actively develop the "Internet + Medicine" innovation model, and provide consumers with more comprehensive services through online and offline methods. Although the initial investment may be large, it will certainly win the first-mover competitive advantage. Finally, how the industry is headed in the future, how the industry is welcoming change is a topic that governments, industry, and companies need to discuss together. Everyone should jointly promote the sustainable and healthy development of pharmaceutical logistics, contribute to the implementation of the healthy China strategy, and contribute to building a well-off society in an all-round way to jointly meet the new era of pharmaceutical logistics development!
The Plastic Padlock seals include a fixed-length indicative wire hasp security seals and whole plastic padlock seals. The application of a padlock seals can be : Meters, Doors, Hatches, In-bond Shipments, Bags, Scales,Tankers,Tote Boxes,Trailers, Airline Bar Boxes, Pouches etc.
The plastic material for the padlock seals can be PP, PC, ABS. The transparent padlock only can use PC material. In order to resist the environment affection, UV additives can be applied to extand the seal life. Or can be a security feature for identification.
The plastic padlock seals can be marked by heat stamp or laser engraving. A logo, serial number , barcode , QR code are possible to be personalized on the seals.
Plastic Padlock Seals,Plastic Padlock Seal,PP Material Padlock Seals,transparent Shell Padlocks Wenzhou Haoshi Light Industrial Products Co., LTD , https://www.economicseals.com